Combination chemotherapy of doxorubicin and paclitaxel for hepatocellular carcinoma in vitro and in vivo.
about
Inhibition of STAT3 dimerization and acetylation by garcinol suppresses the growth of human hepatocellular carcinoma in vitro and in vivo.Effects of Near-infrared Laser Irradiation of Biodegradable Microspheres Containing Hollow Gold Nanospheres and Paclitaxel Administered Intraarterially in a Rabbit Liver Tumor Model.Multifunctional nanocarriers for simultaneous encapsulation of hydrophobic and hydrophilic drugs in cancer treatment.γ-Tocotrienol is a novel inhibitor of constitutive and inducible STAT3 signalling pathway in human hepatocellular carcinoma: potential role as an antiproliferative, pro-apoptotic and chemosensitizing agent.Two hits are better than one: synergistic anticancer activity of α-helical peptides and doxorubicin/epirubicinDelivering hydrophilic and hydrophobic chemotherapeutics simultaneously by magnetic mesoporous silica nanoparticles to inhibit cancer cells.Alpha fetoprotein antagonizes apoptosis induced by paclitaxel in hepatoma cells in vitroAssessing Therapeutic Potential of Magnetic Mesoporous Nanoassemblies for Chemo-Resistant Tumors.Targeted delivery of paclitaxel and doxorubicin to cancer xenografts via the nanoparticle of nano-diamino-tetrac.Molecular-targeted nanotherapies in cancer: enabling treatment specificity.JD enhances the anti-tumour effects of low-dose paclitaxel on gastric cancer MKN45 cells both in vitro and in vivo.Resistance to paclitaxel in hepatoma cells is related to static JNK activation and prohibition into entry of mitosis.In vitro and in vivo conditional sensitization of hepatocellular carcinoma cells to TNF-induced apoptosis by taxolPaclitaxel-loaded nanoparticles decorated with bivalent fragment HAb18 F(ab')2 and cell penetrating peptide for improved therapeutic effect on hepatocellular carcinoma.
P2860
Q30576918-8E9ED0E2-ECC7-474E-8DCD-8A071EA92550Q34160984-258EF498-1C0F-46BA-858B-2555E954C276Q34440323-AF0E8A03-4FD4-4815-902D-B376AB0EDA1CQ34919598-429E3D56-F0D1-4DE6-A848-257DBE4D276AQ35176436-C0006488-9C58-496A-8518-46EBDACCEF9CQ35797575-4B19DCA3-A36F-449B-8917-63AA151BA8E9Q36965059-5880C8AB-F6F3-4DB9-97F3-358F46F7AEA4Q37112958-09C47784-8E6E-410A-909B-97C9892BBBCEQ37652873-B735A599-3813-41C7-AAA0-0D1153460589Q37954497-0E82D0E1-B93C-4F13-A4D5-383785E42B69Q38736541-C2BAAA8F-855D-4A89-BB8C-CA0749242F5CQ39398543-ADA7AE0D-4CBE-4E55-A8EF-BA45C145B34AQ41967143-721BC1D5-7B2A-424B-B90A-F3AF3E0A54E9Q51813743-3CA6CA55-C700-4CC6-8B7C-1755191ACDD8
P2860
Combination chemotherapy of doxorubicin and paclitaxel for hepatocellular carcinoma in vitro and in vivo.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Combination chemotherapy of do ...... arcinoma in vitro and in vivo.
@en
Combination chemotherapy of do ...... arcinoma in vitro and in vivo.
@nl
type
label
Combination chemotherapy of do ...... arcinoma in vitro and in vivo.
@en
Combination chemotherapy of do ...... arcinoma in vitro and in vivo.
@nl
prefLabel
Combination chemotherapy of do ...... arcinoma in vitro and in vivo.
@en
Combination chemotherapy of do ...... arcinoma in vitro and in vivo.
@nl
P2093
P1476
Combination chemotherapy of do ...... carcinoma in vitro and in vivo
@en
P2093
Kefeng Dou
Wenjie Song
Yunxin Cao
P2860
P2888
P304
P356
10.1007/S00432-009-0658-5
P50
P577
2009-08-20T00:00:00Z